Prosecution Insights
Last updated: April 19, 2026

Asterias Biotherapeutics, Inc.

5 pending office actions

Portfolio Summary

5
Total Pending OAs
4
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18262909 COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURIES SMITH, ADAM MICHAEL 1638 Non-Final OA Jul 25, 2023
18074272 DORSALLY-DERIVED OLIGODENDROCYTE PROGENITOR CELLS FROM HUMAN PLURIPOTENT STEM CELLS BERTOGLIO, VALARIE E 1632 Final Rejection Dec 02, 2022
17406074 PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PROGENITOR CELLS FOR THE TREATMENT OF SPINAL CORD INJURY MOSS, NATALIE M 1653 Final Rejection Aug 18, 2021
16862559 SUSPENSION CULTURE OF HUMAN EMBRYONIC STEM CELLS PAPCIAK, SHARON M 1657 Final Rejection Apr 29, 2020
16333566 PLURIPOTENT STEM CELL-DERIVED OLIGODENDROCYTE PROGENITOR CELLS FOR THE TREATMENT OF SPINAL CORD INJURY CONNORS, ALEXANDRA F 1634 Final Rejection Mar 14, 2019

Managing Asterias Biotherapeutics, Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month